Session Details

[1LS06]ISHpalette™: The Dazzling Future of in situ shHCR Applications

Tue. Dec 1, 2026 12:55 PM - 1:45 PM JST
Tue. Dec 1, 2026 3:55 AM - 4:45 AM UTC
Room 6 (Conference Center 3F 311+312)
Chairperson: Aki makanae (Nepa Gene Co., Ltd.)
Nepa Gene Co., Ltd.
The in situ HCR (Hybridization Chain Reaction) method is a novel ISH technique that utilizes the self-assembly reaction of nucleic acids with hairpin structures. While achieving both high-sensitivity detection at a single copy mRNA level and simultaneous staining of multiple targets, it has a lower barrier to adoption compared to conventional methods and has been increasingly adopted by many researchers in recent years. The in situ shHCR method, which uses "ISHpalette™"—labeled hairpin DNAs engineered with even shorter DNA strands, features dramatically improved tissue penetration of the hairpin DNA. This advancement simplifies the staining procedure while allowing us to offer the product at a lower price. Furthermore, combining it with the "TiYO™" autofluorescence quenching device enables high-definition expression detection and multi-round staining. Moreover, recent technological innovations have significantly expanded the range of compatible applications, including bright-field multiplex detection and applications in Tyramide Signal Amplification (TSA).
In this luncheon seminar, we are pleased to welcome Dr. Yousuke Tsuneoka from Toho University, who has collaborated with us in developing these related products. He will give a lecture on the latest technologies currently under development and the future prospects of the in situ shHCR method. This is a valuable opportunity to learn about the latest research trends and technological advancements. Please stay tuned for the future of in situ shHCR !